Depressive symptoms in peripheral arterial disease: A follow-up study on prevalence, stability, and risk factors

Smolderen, Kim G.; Aquarius, Annelies E.; Vries, Jolanda De; Smith, Otto Robert Frans; Hamming, Jaap F.; Denollet, Johan

doi:10.1016/j.jad.2007.12.238

Cited by 68 publications

(72 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Finally, the groupbased trajectory prediction model outperformed models with raw VE scores at baseline, and 2-month follow-up, but had similar predictive power as raw VE scores at 12-month follow-up. The results of the present study advocate the use of latent growth mixture modelling to study the course of symptom levels over time, which has also been argued in other studies (Kaptein et al 2006 ;Martens et al 2008 ;Pedersen et al 2008 ;Smolderen et al 2008). Similar to our study, these investigations have also found support for multiple rather than one trajectory, although they studied depression (Kaptein et al 2006 ;Martens et al 2008 ;Smolderen et al 2008) and anxiety .…”

Section: Discussionsupporting

confidence: 84%

“…VE has been shown to relate to increased lipid metabolism (van Doornen & van Blokland, 1989), hypocortisolaemia (Keltikangas-Järvinen et al 1996 ;Nicolson & van Diest, 2000), reduced fibrinolytic capacity (Kop et al 1998 ;van Diest et al 2002), parasympathetic withdrawal (Watanabe et al 2002), reduced heart rate recovery after exercise (von Kanel et al 2009) and increased levels of cytokines, e.g. interleukin-6 (van der Ven et al 2003 ;Janszky et al 2005).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Vital exhaustion and cardiovascular prognosis in myocardial infarction and heart failure: predictive power of different trajectories

et al. 2010

View full text Add to dashboard Cite

Vital exhaustion and cardiovascular prognosis in myocardial infarction and heart failure Smith, O.R.F.; Kupper, N.; Denollet, Johan; de Jonge, P. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.-Users may download and print one copy of any publication from the public portal for the purpose of private study or research -You may not further distribute the material or use it for any profit-making activity or commercial gain -You may freely distribute the URL identifying the publication in the public portal Take down policyIf you believe that this document breaches copyright, please contact us providing details, and we will remove access to the work immediately and investigate your claim. Background. We examined the different trajectories of vital exhaustion (VE) over a 12-month period and their impact on prognosis in a sample of myocardial infarction (MI) and chronic heart failure (CHF) patients.Method. Consecutive MI (n=407) and CHF patients (n=297) were assessed at baseline, and at 3-and 12-month follow-up for symptoms of VE. Latent growth mixture modelling was used to examine the course of VE over time.The combined clinical endpoint was defined as cardiac hospital readmission or death.Results. Four distinct trajectories for VE were found : low VE, decreasing VE, increasing VE, and severe VE. Conclusions. VE trajectories varied across cardiac patients, and had a differential effect on cardiovascular outcome. Increasing VE and severe VE classes were predictors of poor cardiovascular prognosis. These results suggest that identification of cardiac patients with an increased risk of adverse health outcomes should be based on multiple assessments of VE.

show abstract

Section: Discussionsupporting

confidence: 84%

Section: Introductionmentioning

confidence: 99%

Vital exhaustion and cardiovascular prognosis in myocardial infarction and heart failure: predictive power of different trajectories

et al. 2010

View full text Add to dashboard Cite

show abstract

“…Depression has been reported to occur in approximately one out of five patients with PAD, while the average prevalence of depression in later life has been estimated to be 13% in community-dwelling people. [2][3][4][5] PAD patients with depression have been described to have greater impairment of lower extremity functioning, 4 more functional decline, 6 and to be at greater risk for poor long-term outcomes. 7 Interventions in PAD are primarily aimed at relieving symptoms and disease burden.…”

Section: Introductionmentioning

confidence: 99%

Percutaneous transluminal angioplasty: Association between depressive symptoms and diminished health status benefits

et al. 2011

View full text Add to dashboard Cite

Depressive symptoms are known to compromise health status in cardiac disease, but this relationship has not been described in peripheral artery disease (PAD). Depressive symptoms (PHQ-9) and disease-specific health status (Peripheral Artery Questionnaire, PAQ) were assessed in 242 PAD patients undergoing percutaneous transluminal angioplasty (PTA) at baseline and 1 year. Patients were classified by baseline and follow-up depression status (moderate-severe depressive symptoms = PHQ ≥ 10). Changes were categorized as no depression/improvement of depression versus persistent/worsened depression. At baseline, 20% of patients were depressed; at 1 year, 17% of patients experienced persistent/worsened depression. Although this group improved on most PAQ subscales, they improved to a significantly lesser degree than those without depressive symptoms or those who improved by 1 year (p-values < 0.05). Baseline depressive symptoms (B per 5-point increment = -11.9, 95% CI -15.3, -8.5, p < 0.0001) and changes in depression were independently associated with a decrease in 1-year health status (B per 5-point increment = -11.7, 95% CI -14.3, -9.2, p < 0.0001).In conclusion, depressive symptoms are associated with less improvement in health status 1 year after undergoing a peripheral endovascular revascularization (PER) as compared with those having no depression or whose depressive symptoms improve. Efforts to improve depression detection and treatment among patients with PAD may improve the health status outcomes of these patients.

show abstract

“…Nevertheless, these results were also observed by other WIQ validation studies 6,7 , suggesting that, somehow, the ambulation limitations are related to the emotional status of the individuals with IC. In fact, studies have suggested that the functional limitation of the individuals with IC is related to the occurrence of emotional problems, such as depression 16,17 and stress 18 .…”

Section: Discussionmentioning

confidence: 99%

Tradução e validação do Walking Impairment Questionnaire em brasileiros com claudicação intermitente

Ritti‐Dias¹,

Gobbo²,

Cucato³

et al. 2009

Arq. Bras. Cardiol.

View full text Add to dashboard Cite

show abstract

Depressive symptoms in peripheral arterial disease: A follow-up study on prevalence, stability, and risk factors

Cited by 68 publications

References 34 publications

Vital exhaustion and cardiovascular prognosis in myocardial infarction and heart failure: predictive power of different trajectories

Vital exhaustion and cardiovascular prognosis in myocardial infarction and heart failure: predictive power of different trajectories

Percutaneous transluminal angioplasty: Association between depressive symptoms and diminished health status benefits

Tradução e validação do Walking Impairment Questionnaire em brasileiros com claudicação intermitente

Contact Info

Product

Resources

About